跳至主要内容
临床试验/NCT03831854
NCT03831854已完成3 期

The Role of Lamotrigine in Reducing Psychologic Side-Effect of Perioperative Ketamine Use

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2019年1月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
46
试验地点
1
主要终点
Number of Patients With Psychologic Disturbances-

研究概览

简要总结

Patient will receive lamotrigine vs. placebo with small sips of water. Lamotrigine reaches peak level 1-4 hours after oral administration.

详细描述

1:1 randomization without stratification use web-based software (Redcap) before surgery. Allocation will be concealed from the patient, the nurse, the operating room team. Both patient and the operating room team will be blinded to the treatment allocation (double blind).

Standard preoperative care as per anesthesia care team. Patient will receive lamotrigine vs. placebo with small sips of water. Lamotrigine reaches peak level 1-4 hours after oral administration. Single dose lamotrigine is safe and is not associated with rash.

Standard intraoperative care as per the anesthesia care team. All patients will receive Ketamine 1 mg/kg at induction. Ketamine 5mcg/kg/min will be started at induction and stopped at the end of surgery.

Standard postoperative care as per PACU team. The psychologic side-effects will be measured using Brief Psychiatric Rating Scale (BPRS) using an online tool.

Research fellow will receive standardized training in administering BPRS from Dr. Amit Anand using structured material. Dr. Anand has used this training for other current research projects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The Pharmacy will know the treatment

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 -65 Years of age
  • Planned overnight hospital stay

排除标准

  • Pregnant and planning to become pregnant
  • No known History of seizure
  • No known History of Schizophrenia
  • No known History of unstable angina
  • Patients taking Antiepileptic medications
  • Known history of Lamotrigine intake in past.
  • Any history of allergic reaction to lamotrigine in the past.

研究组 & 干预措施

lamotrigine

Active Comparator

Patient will receive 300 mg of oral lamotrigine with small sips of water to reduce the psychologic side effects (measured by four key items of Brief Psychiatric Rating Scale: conceptual disorganization, hallucinatory behavior, suspiciousness, and unusual thought content) of intraoperative ketamine use.

干预措施: Lamotrigine 300 MG (Drug)

lamotrigine

Active Comparator

Patient will receive 300 mg of oral lamotrigine with small sips of water to reduce the psychologic side effects (measured by four key items of Brief Psychiatric Rating Scale: conceptual disorganization, hallucinatory behavior, suspiciousness, and unusual thought content) of intraoperative ketamine use.

干预措施: Ketamine (Drug)

Placebo

Placebo Comparator

Patient will receive oral Placebo with small sips of water, to reduce the psychologic side effects (measured by four key items of Brief Psychiatric Rating Scale: conceptual disorganization, hallucinatory behavior, suspiciousness, and unusual thought content) of intraoperative ketamine use.

干预措施: Placebo (Drug)

Placebo

Placebo Comparator

Patient will receive oral Placebo with small sips of water, to reduce the psychologic side effects (measured by four key items of Brief Psychiatric Rating Scale: conceptual disorganization, hallucinatory behavior, suspiciousness, and unusual thought content) of intraoperative ketamine use.

干预措施: Ketamine (Drug)

结局指标

主要结局

Number of Patients With Psychologic Disturbances-

时间窗: Up to 90 minutes of PACU arrival

The psychologic side-effects were measured in PACU (up to 90 minutes after ketamine infusion). This included four key items of the Brief Psychiatric Rating Scale (BPRS) corresponding to positive symptoms of schizophrenia: conceptual disorganization, hallucinatory behavior, suspiciousness, and unusual thought content. Each symptom is rated 1-7 ( 1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe ), and, therefore, the total score as the primary outcome based on four key items of BPRS will be between 4 (best score) and 28 (worst score). Patients who had a total score of 4 (all symptoms not present) were determined as not having psychologic disturbance and patients who had a total score of \> 4 (having any symptoms present) were determined as having psychologic disturbance.

Psychologic Side-effects

时间窗: in PACU (up to 90 minutes after ketamine infusion)

The primary outcome of psychologic side-effects was measured in PACU (up to 90 minutes after ketamine infusion). This included four key items of the Brief Psychiatric Rating Scale (BPRS) corresponding to positive symptoms of schizophrenia: conceptual disorganization, hallucinatory behavior, suspiciousness, and unusual thought content. Each symptom is rated 1-7 ( 1 = not present, 2 = very mild, 3 = mild, 4 = moderate, 5 = moderately severe, 6 = severe, 7 = extremely severe ), and, therefore, the total score as the primary outcome based on four key items of BPRS will be between 4 (best score) and 28 (worst score).

次要结局

  • Total Opioid Consumption in PACU (mg)(from entry to PACU to leaving PACU, up to 4 hours)
  • Pain Score in PACU(from entry to PACU to leaving PACU)
  • Number of Patients Who Had PONV (Postoperative Nausea Vomiting)(after surgery up to discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验